AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 52 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,390,370 | -2.6% | 249,808 | +23.0% | 0.00% | – |
| Q2 2023 | $3,482,444 | -7.9% | 203,058 | +8.3% | 0.00% | – |
| Q1 2023 | $3,781,854 | +72183.1% | 187,499 | +5.0% | 0.00% | -100.0% |
| Q4 2022 | $5,232 | -99.8% | 178,596 | +5.3% | 0.00% | – |
| Q3 2022 | $2,811,000 | +8.2% | 169,599 | +2.1% | 0.00% | – |
| Q2 2022 | $2,597,000 | -27.4% | 166,162 | -14.9% | 0.00% | – |
| Q1 2022 | $3,577,000 | +92.4% | 195,187 | +23.7% | 0.00% | – |
| Q4 2021 | $1,859,000 | -22.5% | 157,730 | +37.8% | 0.00% | – |
| Q3 2021 | $2,400,000 | – | 114,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $17,690,227 | 28.88% |
| Atlas Venture Life Science Advisors, LLC | 2,017,521 | $59,113,365 | 7.12% |
| Sofinnova Investments, Inc. | 3,758,686 | $110,129,500 | 6.54% |
| TCG Crossover Management, LLC | 1,081,274 | $31,681,328 | 5.59% |
| RA Capital Management | 8,263,982 | $242,134,673 | 4.91% |
| Cormorant Asset Management, LP | 1,957,132 | $57,344 | 3.84% |
| VR Adviser, LLC | 747,869 | $21,912,562 | 3.69% |
| Octagon Capital Advisors LP | 621,712 | $18,216,162 | 2.84% |
| GREAT POINT PARTNERS LLC | 378,522 | $11,090,695 | 2.17% |
| Ghost Tree Capital, LLC | 135,000 | $3,956,000 | 1.69% |